Neo-Concept International Group Holdings Limited (NCI) Stock Price

Live Neo-Concept International Group Holdings Limited Stock Price, Historical NCI Stock Price Chart

24H Range
 
 
 
52W Range
 
 
 
Last Price $ 5.36
Open $ 5.12
Previous Close $ 5.12
Volume $ 108,502
ATH $ 455.60 (-98.82%)
ExchangeNASDAQ
P/E Ratio (TTM) -
EPS (TTM) $ 0.00
Annual Dividend (Yield) $ 0.00 (0.00%)
Market Cap $ 5.59M
Neo-Concept International Group Holdings Limited Performance
Prev. Close 7 Days 1 Month 3 Months 6 Months 1 Year YTD 5 Year Max
4.69% 15.54% -2.76% -94.50% -91.63% -91.63% -92.65% -99.82% -99.82%

About Neo-Concept International Group Holdings Limited

Statistics

The Neo-Concept International Group Holdings Limited stock price is currently $ 5.36 with a total market cap valuation of $ 5.59M (1.04M shares outstanding). The Neo-Concept International Group Holdings Limited is trading on NASDAQ under the ticker sign NCI. Neo-Concept International Group Holdings Limited price is up 4.69% in the past 24 hours. The Neo-Concept International Group Holdings Limited stock price prediction is currently bullish.

Description

Company Profile

  • Full Name: Neo-Concept International Group Holdings Limited
  • Sector: Consumer Cyclical
  • Website: https://www.neo-ig.com

News

Acrivon to Present Late-Breaking Oral Plenary Presentation and Posters at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Neo-Concept International Announces Share Consolidation
Purple Biotech Announces IM1240 Abstract Selected for Oral Presentation at the 38th EORTC-NCI-AACR Symposium
Adlai Nortye Announces Oral Presentation for AN4035 Program Update at the Upcoming 38th EORTC-NCI-AACR Symposium
Pyxis Oncology to Present Micvotabart Pelidotin (MICVO) Phase 1 Monotherapy Data in Late-Breaking Oral Presentation and Two Poster Presentations at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
$2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma
Neo-Concept International Group Holdings Ltd Announces Pricing of $2.0 Million Registered Direct Offering
Exelixis Announces Results from Subgroup Analysis of Phase 3 CABINET Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Non-Functional and Functional Neuroendocrine Tumors at ASCO 2026
Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer
NTG Clarity Networks Inc. (NCI:CA) Q1 2026 Earnings Call Transcript

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

NCI
Neo-Concept International Group Holdings Limited
$ 5.36
15.54%   Last 7D
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Updated a day ago